Toronto Dominion Bank Exagen Inc. Transaction History
Toronto Dominion Bank
- $58 Billion
- Q2 2025
A detailed history of Toronto Dominion Bank transactions in Exagen Inc. stock. As of the latest transaction made, Toronto Dominion Bank holds 851,289 shares of XGN stock, worth $8.14 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
851,289
Previous 891,366
4.5%
Holding current value
$8.14 Million
Previous $3.2 Million
85.66%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding XGN
# of Institutions
52Shares Held
9.08MCall Options Held
0Put Options Held
0-
Rtw Investments, LP New York, NY1.7MShares$16.2 Million0.18% of portfolio
-
Balyasny Asset Management LLC Chicago, IL719KShares$6.87 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA682KShares$6.52 Million0.0% of portfolio
-
Silvercrest Asset Management Group LLC New York, NY532KShares$5.08 Million0.03% of portfolio
-
Morgan Stanley New York, NY525KShares$5.02 Million0.0% of portfolio
About EXAGEN INC.
- Ticker XGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 16,260,400
- Market Cap $155M
- Description
- Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...